Portal de Periódicos da CAPES

Diabetes and its complications: Blood glucose control vs. genetic susceptibility

1988; Wiley; Volume: 4; Issue: 5 Linguagem: Inglês

10.1002/dmr.5610040502

1099-0895

Julio Rosenstock, Philip Raskin,

Metabolism and Genetic Disorders

Diabetes/Metabolism ReviewsVolume 4, Issue 5 p. 417-435 Diabetic Complication Diabetes and its complications: Blood glucose control vs. genetic susceptibility Julio Rosenstock, Julio Rosenstock Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235Search for more papers by this authorPhilip Raskin, Philip Raskin Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235Search for more papers by this author Julio Rosenstock, Julio Rosenstock Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235Search for more papers by this authorPhilip Raskin, Philip Raskin Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235Search for more papers by this author First published: August 1988 https://doi.org/10.1002/dmr.5610040502Citations: 21AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Hanssen KF, Dahl-Jorgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hanssen O, and Deckert T: Diabetic control and microvascular complications: The near-normoglycaemic experience. Diabetologia 29: 677–685, 1986. 2 Raskin P: Diabetic regulation and its relationship to microangiopathy. Metabolism 27: 235–251, 1978. 3 Barbosa J, and Sone B: Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia 27: 487–492, 1984. 4 Raskin P, and Rosenstock J: Blood glucose control and diabetic complications. Ann Intern Med 105: 254–163, 1986. 5 Raskin P: Treatment of insulin-dependent diabetes with portable insulin infusion devices. Med Clin North Am 66: 1269–1283, 1982. 6 Rosenstock J, Strowig S, and Raskin P: Insulin pump therapy. A realistic appraisal. Clinical Diabetes 3: 25–31, 1985. 7 Unger RH: Meticulous control of diabetes: Benefits, risks and precautions. Diabetes 31: 479–483, 1982. 8 The DCCT Research Group: Diabetes control and complications trial (DCCT): Results of feasibility study. Diabetes Care 10: 1–19, 1987. 9 Palmberg P, Smith M, Waltman S, Krupin T, Singer P, Burgess D, Wendtlant T, Achtemberg J, Cryer PM, Santiago J, White N, Kilo C, and Daugharday W: The natural history of retinopathy in insulin-dependent juvenile-onset diabetes. Ophthalmology 88: 613–618, 1981. 10 Klein R, Klein BEK, Moss SE, Davis ME, and DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when eye at diagnosis is less than 30 years. Arch Ophthalmol 102: 520–526, 1984. 11 Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, and Kahn CR: Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: A 40 year follow-up study. Diabetes Care 1986; 9: 443–452. 12 Oakley WG, Pyke DA, Tattersall RB, and Watkins PJ: Long-term diabetes: A clinical study of 92 patients after 40 years. Quart J Med 43: 145–156, 1974. 13 Paz-Guevara AT, Hsu TH, and White P: Juvenile diabetes mellitus after forty years. Diabetes 24: 559–565, 1975. 14 Kussman MJ, Goldstein HH, and Gleason RE: The clinical course of diabetic nephropathy. J Am Med Assoc 236: 1861–1863, 1976. 15 Andersen AK, Christiansen JS, Andersen JK, Kreiner S, and Deckert T: Diabetic nephropathy in type I (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25: 496–501, 1983. 16 Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, and Deckert T: Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes 36: 2056–2059, 1987. 17 Krolewski AS, Warram JH, Christlieb AR, Busick EJ, and Kahn DR: The changing natural history of nephropathy in type I diabetes. Am Med J 78: 785–794, 1985. 18 Krolewski AS, Warrem JH, Rand LI, and Kahn CR: Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317: 1390–1398, 1987. 19 Siperstein MD, Unger RH, and Madison LL: Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest 47: 1973–1999, 1968. 20 Kilo C, Vogler N, and Williamson JR: Muscle capillary basement membrane changes related to aging and to diabetes mellitus. Diabetes 21: 881–905, 1972. 21 Williamson JR, Rowold E, Hoffman P, and Kilo CL: Influence of fixation and morphometric technics on capillary basement-membrane thickening prevalence data in diabetes. Diabetes 25: 604–613, 1976. 22 Vracko RL: Skeletal muscle capillaries in diabetics; a quantitative analysis. Circulation 41: 271–183, 1970. 23 Pardo V, Perez-Stable E, Alzamora DB, and Cleveland WW: Incidence and significance of muscle capillary basal albumin thickness in juvenile diabetes. Am J Pathol 68: 67–80, 1972. 24 Danowski TS, Fisher ER, Khurana RC, Nolan S, and Stephan TL: Muscle capillary basement membrane in juvenile diabetes mellitus. Metabolism 21: 1125–1132, 1972. 25 Siperstein MD, Raskin P, and Burns H: Electron microscopic quantification of diabetic microangiopathy. Diabetes 22: 514–527, 1973. 26 Raskin P, Marks JF, Burns H Jr., Plumer MD, and Siperstein MD: Capillary basement membrane width in diabetic children. Am J Med 58: 365–372, 1975. 27 Raskin P, Pietri A, Unger R, and Shannon WA Jr.: The effect of diabetic control on skeletal muscle capillary basement membrane width in patients with type I diabetes mellitus. N Engl J Med 309: 1546–1550, 1983. 28 Rosenstock J, Challis P, Strowig S, and Raskin P: Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent diabetes mellitus. Diabetes Res Clin Prac, 4: 167–175, 1988 29 Feingold KR, Lee TH, Chung MY, and Siperstein MD: Muscle capillary basement membrane width in patients with Vacor-induced diabetes mellitus. J Clin Invest 78: 102–107, 1986. 30 Donan TL, Ting A, McPherson CK, Peckar CO, Mann JI, Turner RC, and Morris PJ: Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes 31: 226–231, 1982. 31 Christy M, Nerup J, Platz P, Thomsen M, Ryder LP, and Svejgaard A: A review of HLA antigens in longstanding IDDM with and without severe retinopathy. Horm Metab Res 11 (suppl): 73–77, 1981. 32 Johnston PB, Kidd M, Middleton D, Greenfield AA, Archer DB, Maguire CJF, and Kennedy L: Analysis of HLA antigen association with proliferative diabetic retinopathy. Br J Ophthalmol 66: 277–279, 1982. 33 Gray RS, Starkey IR, Rainbow S, Kurtz AB, Abdel-Khalik A, Urbaniak S, Elton RA, Duncan LJP, and Clarke BF: HLA antigens and other risk factors in the development of retinopathy in type 1 diabetes. Br J Ophthalmol 66: 280–285, 1982. 34 Marks JR, Raskin P, and Stastny P: Increase in capillary basement membrane width in parents of children with type I diabetes mellitus: Association with HLA-DR4. Diabetes 30: 475–480, 1981. 35 Rosenstock J, Marks J, Stastny P, and Raskin P: The relationship of HLA-DR4 locus to diabetic microvascular complications; Genes or glycemia. Diabetes, 32 (Suppl 1): 24A, 1988. 36 Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowles WC, and Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140–145, 1988. 37 Mangili R, Bending JJ, Scott G, Li LK, Gupta A, and Vibeti GC: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 18: 146–150, 1988. 38 Engerman R, Finkelstein D, Aguirre G, Diddie Kr, Fox RR, Frank RN, and Varma SD: Ocular complications. Diabetes 31 (suppl 1): 82–88, 1982. 39 Engerman R, Bloodworth JMB, and Nelson S: Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760–769, 1977. 40 Miller K, and Michael AF: Immunopathology of renal extracellular membranes in diabetes mellitus: Specificity of tubular basement membrane immunofluorescence. Diabetes 25: 701–708, 1976. 41 Lee CS, Mauer SM, Brown DM, Sutherland DER, Michael AF, and Najarian JS: Renal transplantation in diabetes mellitus in rats. J Exp Med 139: 793–800, 1974. 42 Mauer SM, Steffes MW, Sutherland DER, Najarian JS, Michael AF, and Brown DM: Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes 24: 280–285, 1975. 43 Mauer SM, Miller K, Goetz FC, Barbosa J, Simmons RL, Najarian JS, and Michael AF: Immunopathology of renal extracellular membranes in kidneys transplanted into patients with diabetes mellitus. Diabetes 25: 709–712, 1976. 44 Mauer SM, Barbosa J, Vernier RL, Kjellstrand CM, Buselmeier TJ, Simmons RL, Najarian JS, and Goetz FC: Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med 295: 916–920, 1976. 45 Abouna GM, Al-Adnani MS, Kremer GD, Kumar SA, Daddah SK, and Kusma G: Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into nondiabetic recipients. Lancet 2: 1274–1276, 1983. 46 Bilous RW, Steffer MW, Guetz FC, Sutherland DER, and Mauer SM: Pancreas transplantation for more than two years ameliorates glomerular pathology in insulin-dependent diabetic patients. Diabetic Med 4: 554A, 1987. 47 Cerami A, Stevens VJ, and Mannier VM: Role of nonenzymatic glycosylation in the development of the sequelae of diabetes mellitus. Metabolism 28 (suppl 1): 431–432, 1979. 48 Greene DA, Lattimer SA, and Simon AAF: Sorbitol, phosphoinositides and sodium potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599–606, 1987. 49 Zatz R, Meyer TW, Rennke HG, and Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci 82: 5963–5962, 1985. 50 Johnsson SL: Retinopathy and nephropathy in diabetes mellitus: Comparison of the effect of two forms of treatment. Diabetes 9: 1–8, 1960. 51 Pirart J: Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabete Metab 3: 97–107, 1977. 52 Job D, Eshwege E, Guyot-Argenton C, Aubry JP, and Tchobbroutsky G: Effect of multiple daily insulin injections on the course of retinopathy. Diabetes 25: 463–469, 1976. 53 Lauritzen T, Frost-Larsen K, Larsen HW, and Deckert T: Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1: 200–204, 1983. 54 Lauritzen T, Frost-Larsen K, Larsen HW, and Deckert T: Steno Study Group: Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 34 (suppl 3): 74–79, 1985. 55 Deckert T, Lauritzen T, Parving H, and Christensen JS: Steno Study Group: Effect of two years of strict metabolic control on kidney function in long-term insulin-dependent diabetics. Diabetic Nephrop 2: 6–10, 1983. 56 Feldt-Rasmussen B, Matheisen ER, Hegedus L, and Deckert T: Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med 314: 665–670, 1986. 57 Feldt-Rasmussen B, Mathiesen ER, and Deckert T: Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 2: 1300–1304, 1986. 58 Parving HH, Oxenboll B, Svendsen PA, Sandahl-Christiansen J, and Anderson AR: Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endrocrinol 100: 550–555, 1982. 59 Viberti GC, Jarrett RJ, Mahmuc U, Hill RD, Argyropoulos A, and Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–1432, 1982. 60 Mogensen DE, and Christiansen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89–93, 1984. 61 Mathiesen ER, Oxenboll B, Johansen K, Svendesen PA, and Deckert T: Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 26: 406–410, 1984. 62 The Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria: A preliminary multicenter trial. N Engl J Med 311: 365–372, 1984. 63 The Kroc Collaborative Study Group: The Kroc Study patients at two years: A report on further retinal changes [Abstract]. Diabetes 34 (suppl 1): 39A, 1985. 64 Rosenstock J, and Raskin P: Early diabetic nephropathy. Assessment and potential therapeutic interventions. Diabetes Care 9: 529–545, 1986. 65 Homan RR, Dorman TL, Mayon-White V, Orde-Peckar C, Steemson J, Smith B, McPherson K, Rizza C, Knight AH, Dornan TL, Howard-Williams J, Jenkins L, Rolfe R, Barbour D, Poon Pyw, Mann JI, Bron AJ, and Turner RC: Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients: A two-year randomized prospective study. Lancet 1: 204–208, 1983. 66 Beck-Neilsen H, Rickelsen B, Mogensen CE, Olsen T, Ehlers N, Nielsen CB, and Charles P: Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care 85: 585–589, 1985. 67 Dahl-Jorgensen K, Brichmann-Hanssen O, Hanssen KF, Sandvik L, and Aagenzes O: Aker Diabetes Group. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin-dependent diabetes mellitus: The Oslo Study. Br Med J 290: 811–815, 1985. 68 Dahl-Jorgensen K, Brichmann-Hanssen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, and Aagenaes O: Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo Study. Br Med J 293: 1195–1199, 1986. 69 Kohner EM, Sleightholm M, and Fallon T: Why does retinopathy deteriorate when diabetic control is improved [Abstract]? Invest Ophthalmol Vis Sci 28 (Suppl): 244, 1987. 70 Raskin P, Pietri A, and Unger RH: Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps. Diabetes 28: 1033–1034, 1979. 71 Pietri A, Dunn FL, and Raskin P: The effect of improved diabetic control on plasma lipid and lipoprotein levels: A comparison of conventional therapy and continuous subcutaneous insulin infusion. Diabetes 29: 1001–1005, 1980. 72 Dunn FL, Pietri A, and Raskin P: Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes. Ann Intern Med 95: 426–431, 1981. 73 Pietri A, Dunn FL, Grundy SM, and Raskin P: The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus. Diabetes 32: 75–81, 1983. 74 Pietri A, Ehli AL, and Raskin P: Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671, 1980. 75 Friberg TR, Rosenstock J, Sanborn G, Vaghefi A, and Raskin P: The effect of long-term near normal glycemic control on mild diabetic retinopathy. Ophthalmology 92: 1051–1058, 1985. 76 Rosenstock J, Friberg T, and Raskin P: The effect of glycemic control on the microvascular complications in patients with type I diabetes mellitus. Am J Med 81: 1012–1018, 1986. 77 Rosenstock J, Strowig S, Cercone S, and Raskin P: Reduction in cardiovascular risk factors with intensive diabetes treatment in type I insulin-dependent diabetes mellitus. Diabetes Care 10: 729–734, 1987. 78 Rosenstock J, Vega G, and Raskin P: The effect of intensive diabetes treatment on low density lipoprotein Apo B kinetics in insulin dependent diabetes mellitus. Diabetes 37: 393–397, 1988. 79 Ramsay RC, Goetz FC, Sutherland DER, Mauer SM, Robinson LL, Cantrill HL, Knobloch WH, and Najarian JS: Progression of diabetic retinopathy after pancreas transplantation for insulin dependent diabetes mellitus. N Engl J Med 318: 208–214, 1988. 80 The DCCT Research Group: Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? N Engl J Med 318: 246–249, 1988. 81 The DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase. Diabetes 35: 530–545, 1986. Citing Literature Volume4, Issue5August 1988Pages 417-435 ReferencesRelatedInformation